Am J Perinatol 2022; 39(04): 416-424
DOI: 10.1055/s-0040-1717068
Original Article

Decision to Incision and Risk for Fetal Acidemia, Low Apgar Scores, and Hypoxic Ischemic Encephalopathy

Autoren

  • Sabine Bousleiman

    1   Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York
  • Dwight J. Rouse

    2   Division of Research, Department of Obstetrics and Gynecology, Women and Infants Hospital, Warren Alpert Medical School at Brown University, Providence, Rhode Island
  • Cynthia Gyamfi-Bannerman

    1   Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York
  • Yongmei Huang

    1   Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York
  • Mary E. D'Alton

    1   Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York
  • Zainab Siddiq

    1   Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York
  • Jason D. Wright

    1   Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York
  • Alexander M. Friedman

    1   Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York

Funding A.M.F. is supported by a career development award (K08HD082287) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.

Abstract

Objective This study aimed to assess risk for fetal acidemia, low Apgar scores, and hypoxic ischemic encephalopathy based on decision-to-incision time interval in the setting of emergency cesarean delivery.

Study Design This unplanned secondary analysis of the Maternal–Fetal Medicine Units prospective observational cesarean registry dataset evaluated risk for hypoxic ischemic encephalopathy, umbilical cord pH ≤7.0, and Apgar score ≤4 at 5 minutes based on decision-to-incision time for emergency cesarean deliveries. Cesarean occurring for nonreassuring fetal heart rate monitoring, bleeding previa, nonreassuring antepartum testing, placental abruption, or cord prolapse was classified as emergent. Decision-to-incision time was categorized as <10 minutes, 10 to <20 minutes, 20 to <30 minutes, 30 to <50 minutes, or ≥50 minutes. As secondary outcomes umbilical cord pH ≤7.1, umbilical artery pH ≤7.0, and Apgar score ≤5 at 5 minutes were analyzed.

Results Of 5,784 women included in the primary analysis, 12.4% had a decision-to-incision interval ≤10 minutes, 20.2% 11 to 20 minutes, 14.9% 21 to 30 minutes, 18.2% 31 to 50 minutes, and 16.5% >50 minutes. Risk for umbilical cord pH ≤7.0 was highest at ≤10 and 11 to 20 minutes (10.2 and 7.9%, respectively), and lowest at 21 to 30 minutes (3.9%), 31 to 50 minutes (3.9%), and >50 minutes (3.5%) (p < 0.01). Risk for Apgar scores ≤4 at 5 minutes was also higher with decision-to-incision intervals ≤10 and 11 to 20 minutes (4.3 and 4.4%, respectively) compared with intervals of 21 to 30 minutes (1.7%), 31 to 50 minutes (2.1%), and >50 minutes (2.0%) (p < 0.01). Hypoxic ischemic encephalopathy occurred in 1.5 and 1.0% of women with decision-to-incision intervals of ≤10 and 11 to 20 minutes compared with 0.3 and 0.5% for women with decision-to-incision intervals of 21 to 30 minutes and 31 to 50 minutes (p = 0.04). Risk for secondary outcomes was also higher with shorter decision-to-incision intervals.

Conclusion Shorter decision-to-incision times were associated with increased risk for adverse outcomes in the setting of emergency cesarean.

Key Points

  • Shorter intervals likely occur with higher risk cases.

  • Shorter intervals were associated with higher neonatal risk.

  • Shorter intervals were associated with low cord pH.



Publikationsverlauf

Eingereicht: 10. Juli 2020

Angenommen: 02. August 2020

Artikel online veröffentlicht:
21. September 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA